ReviewBMJ global health2021
Challenges in reported COVID-19 data: best practices and recommendations for future epidemics.
Review in BMJ global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed.
- Estimating vaccine efficacy during open-label follow-up of COVID-19 vaccine trials based on population-level surveillance data.Epidemics · 2024Trial
- Recommendations for the analysis of leading indicators in epidemic surveillance.PLOS digital health · 2026Review
- Refining the role of behavioural and social sciences in pandemic response post-COVID-19.Nature human behaviour · 2026Review
- The Open Syndrome Definition as a Machine-Readable Standard for Public Health: Design and Implementation Study.Journal of medical Internet research · 2026Article
- Reaching the margins: examining equity in Indonesia's COVID-19 vaccination strategy.BMJ global health · 2026Review
- Evaluation of COVID-19 policy efficiency in 27 European OECD countries: a data envelopment analysis.BMC health services research · 2026Article
- Retrospective analysis of age-specific non-pharmaceutical interventions on wild-type SARS-CoV-2 in Canada.BMC public health · 2026Article
- Reporting of notifiable medical conditions among emergency department doctors in Gauteng.Southern African journal of infectious diseases · 2026Article
- Assessing Usefulness of the Dashboard Instrument to Review Equity (DIRE) Checklist to Evaluate Equity in Public Health Dashboards: Reliability Study.JMIR public health and surveillance · 2025Article
- Can past variants of SARS-CoV-2 predict the impact of future variants? Machine learning for early warning of US counties at risk.Health care management science · 2025Article
- Back-projection improves inference from sparsely sampled genomic surveillance data.bioRxiv : the preprint server for biology · 2025Article
- Measles Tracker: a near-real-time data hub for measles surveillance.JAMIA open · 2025Article
- Building and Developing a Tool (PANDEM-2 Dashboard) to Strengthen Pandemic Management: Participatory Design Study.JMIR public health and surveillance · 2025Article
- Constructing a global human epidemic database using open-source digital biosurveillance.Scientific data · 2025Article
- Consistency of Daily Number of Reported COVID-19 Cases in 191 Countries From 2020 to 2022: Comparative Analysis of 2 Major Data Sources.JMIR public health and surveillance · 2025Article
- What makes an epidemic a disaster: the future of epidemics within the EM-DAT International Disaster Database.BMC public health · 2025Article
- Pathogenic built environment? Reflections on modeling spatial determinants of health in urban settings considering the example of COVID-19 studies.Frontiers in public health · 2025Article
- Article
- Prediction models for COVID-19 disease outcomes.Emerging microbes & infections · 2024Article
- Spatiotemporal Cluster Detection for COVID-19 Outbreak Surveillance: Descriptive Analysis Study.JMIR public health and surveillance · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The proliferation of composite data sources tracking the COVID-19 pandemic emphasises the need for such databases during large-scale infectious disease events as well as the potential pitfalls due to the challenges of combining disparate data sources. Multiple organisations have attempted to standardise the compilation of disparate data from multiple sources during the COVID-19 pandemic. However, each composite data source can use a different approach to compile data and address data issues with varying results.We discuss some best practices for researchers endeavouring to create such compilations while discussing three key categories of challenges: (1) data dissemination, which includes discrepant estimates and varying data structures due to multiple agencies and reporting sources generating public health statistics on the same event; (2) data elements, such as date formats and location names, lack standardisation, and differing spatial and temporal resolutions often create challenges when combining sources; and (3) epidemiological factors, including missing data, reporting lags, retrospective data corrections and changes to case definitions that cannot easily be addressed by the data compiler but must be kept in mind when reviewing the data.Efforts to reform the global health data ecosystem should bear such challenges in mind. Standards and best practices should be developed and incorporated to yield more robust, transparent and interoperable data. Since no standards exist yet, we have highlighted key challenges in creating a comprehensive spatiotemporal view of outbreaks from multiple, often discrepant, reporting sources and provided guidelines to address them. In general, we caution against an over-reliance on fully automated systems for integrating surveillance data and strongly advise that epidemiological experts remain engaged in the process of data assessment, integration, validation and interpretation to identify, diagnose and resolve data challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.